The promise of community-based advocacy and education efforts for increasing cancer clinical trials accrual

Journal of Cancer Education

Volumn 27, Issue 1, 2012, Pages 67-74

  Michaels, Margo ^a   Weiss, Elisa S ^b   Guidry, John A ^c   Blakeney, Natasha ^a   Swords, Liz ^d   Gibbs, Brian ^e   Yeun, Samantha ^f   Rytkonen, Bruce ^f   Goodman, Robert ^g   Jarama, S Lisbeth ^h   Greene, Amanda L ^h   Patel, Shilpa ^b  

^a Education Network to Advance Cancer Clinical Trials (ENACCT)   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Gay Men's Health Crisis   (United States)

^d Decatur Community Partnership   (United States)

^e Cherishing our Hearts and Souls Coalition   (United States)

^f Cross Cultural Collaborative of Pierce County   (United States)

^g INDIANA UNIVERSITY   (United States)

^h NOVA Research Company   (United States)

Author keywords

Clinical trials as topic methods; Community institutional relations; Consumer advocacy; Continuing; Education; Medical; Minority groups; Neoplasms therapy; Nursing; Patient advocacy; Patient education; Patient selection

Indexed keywords

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); CONSUMER ADVOCACY; EDUCATION; FEMALE; GENERAL PRACTITIONER; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PARTICIPATORY RESEARCH; PATIENT EDUCATION; PATIENT PARTICIPATION; PATIENT SELECTION; PILOT STUDY; STATISTICS; UTILIZATION REVIEW;

ADULT; CLINICAL TRIALS AS TOPIC; COMMUNITY-BASED PARTICIPATORY RESEARCH; CONSUMER ADVOCACY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT EDUCATION AS TOPIC; PATIENT PARTICIPATION; PATIENT SELECTION; PHYSICIANS, PRIMARY CARE; PILOT PROJECTS; RESEARCH DESIGN;

EID: 84863728229     PISSN: 08858195     EISSN: 15430154     Source Type: Journal    
DOI: 10.1007/s13187-011-0271-6     Document Type: Article

References (24)

1. The American College of Surgeons Commission on Cancer Standards. Commission on Cancer, Cancer Program Standards. 2009, revised edition. Available from: http://www.facs.org/cancer/coc/cocprogramstandards.pdf Accessed 1 December 2010.
2. National Cancer Institute. Digest Page: Boosting Cancer Trial Participation. Available from: http://www.cancer.gov/clinicaltrials/digestpage/ boosting-trial-participation. Accessed 1 December 2010.
3. Murthy VH, Krumholz HM et al (2004) Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 291 (22):2720-2726.
4. Nass SJ, Moses HL, Mendelsohn J. (eds) (2010) National Cancer Clinical Trials System for the 21st Century: reinvigorating the NCI Cooperative Group Program. Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine of the National Academies.
5. Mills EJ, Seely D et al (2006) Barriers to participation in clinical trials of cancer: a meta-analysis and systematic review of patientreported factors. Lancet Oncol 7(2):141-148.
6. Markman M, Petersen J et al (2008) An examination of the influence of patient race and ethnicity on expressed interest in learning about cancer clinical trials. J Cancer Res Clin Oncol 134 (1):115-118.
7. Jones JM, Nyhof-Young J et al (2006) Identifying motivations and barriers to patient participation in clinical trials. J Cancer Educ 21 (4):237-242.
8. Corbie-Smith G, Thomas SB et al (2002) Distrust, race, and research. Arch Intern Med 162(21):2458-2463.
9. Ford JG, Howerton MW et al (2008) Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer 112(2):228-242.
10. Comis RL, Miller JD et al (2009) Physician-related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract 5(2):50-56.
11. Ford JG, Howerton MW et al. (2005) Knowledge and access to information on recruitment of underrepresented populations to cancer clinical trials (evidence report/technology assessment no. 122). Baltimore (MD): Johns Hopkins University, Evidence-based Practice Center; AHRQ Publication No. 05-E019-2; Contract No. 290-02-0018.
12. Weinberg AD, Cooper HP et al (2004) Attitudes of primary care physicians and specialists about cancer clinical trials: a survey of Texas physicians. Tex Med 100(4):66-72.
13. Crosson K, Eisner E et al (2001) Primary care physicians' attitudes, knowledge and practices related to cancer clinical trials. J Cancer Educ 16(4):188-192.
14. Sherwood PR, Given BA et al (2004) To refer or not to refer: factors that affect primary care provider referral of patients with cancer to clinical treatment trials. J Cancer Educ 19(1):58-65.
15. Chen DT, Miller FG, Rosenstein DL (2003) Clinical research and the physician-patient relationship. Ann Intern Med 138(8):669- 672.
16. Howerton MW, Gibbons MC et al (2007) Provider roles in the recruitment of underrepresented populations to cancer clinical trials. Cancer 109(3):465-476.
17. Sateren WB et al (2002) How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. J Clin Oncol 20(8):2109-2117.
18. Brown RF, Butow PN et al (2007) Seeking informed consent to cancer clinical trials; evaluating the efficacy of doctor communication skills training. Psychooncology 16(6):507-516.
19. Albrecht TL, Blanchard C et al (2008) Influence of clinical communication on patients' decision making on participation in clinical trials. J Clin Oncol 26(16):2666-2673.
20. Joseph G, Dohan D (2009) Diversity of participants in clinical trials in an academic medical center: the role of the 'good study patient?'. Cancer 115(3):608-615, 1.
21. Jenkins V, Fallowfield L et al (2005) Discussing randomized clinical trials of cancer therapy: evaluation of a Cancer Research UK training programme. BMJ 330(7488):400.
22. Paskett ED, Cooper MR et al (2002) Clinical trial enrollment of rural patients with cancer. Cancer Pract 10(1):28-35.
23. Wendler D, Kington R et al (2006) Are racial and ethnic minorities less willing to participate in health research? PLoS Med 3(2):e19, Epub 2005.
24. Rogers EM (2003) Diffusion of innovations, 5th edn. Free Press, New York.